NCT03673501 2026-02-05INTRIGUEDeciphera Pharmaceuticals, LLCPhase 3 Active not recruiting453 enrolled 20 charts
NCT07218926 2026-01-30A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib TherapyGlaxoSmithKlinePhase 3 Recruiting450 enrolled